Compare CTNT & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTNT | XAIR |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7M | 4.3M |
| IPO Year | 2023 | 2015 |
| Metric | CTNT | XAIR |
|---|---|---|
| Price | $1.81 | $6.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 364.6K | 45.3K |
| Earning Date | 05-08-2026 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.74 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,288,536.00 | ★ $7,679,000.00 |
| Revenue This Year | $42.49 | $122.00 |
| Revenue Next Year | $22.22 | $58.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 182.69 | 107.26 |
| 52 Week Low | $0.02 | $0.33 |
| 52 Week High | $4.21 | $8.19 |
| Indicator | CTNT | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 54.87 | 72.32 |
| Support Level | $1.47 | $0.59 |
| Resistance Level | $1.95 | $8.19 |
| Average True Range (ATR) | 0.16 | 0.44 |
| MACD | 0.03 | -0.07 |
| Stochastic Oscillator | 70.91 | 43.83 |
Cheetah Net Supply Chain Service Inc is a provider of logistics and warehousing services, historically in connection with the sale of parallel-import vehicles sourced in the U.S. to be sold in the PRC market, and more recently for the transportation of other goods between the U.S. and the PRC. Parallel-import vehicles in the PRC refer to automobiles purchased directly from overseas markets and imported for sale outside of the brand manufacturer's official distribution networks. The company operates as single report segment. The company operates in the USA and overseas.
Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.